ArticleThe Lancet regional health. Europe2025

PD-L1 inhibitors combined with chemotherapy for extensive-stage small cell lung cancer: a French nationwide cohort study.

Hugo Jourdain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.